Does TECLISTAMAB-CQYV Cause Muscular weakness? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Muscular weakness have been filed in association with TECLISTAMAB-CQYV. This represents 0.6% of all adverse event reports for TECLISTAMAB-CQYV.
9
Reports of Muscular weakness with TECLISTAMAB-CQYV
0.6%
of all TECLISTAMAB-CQYV reports
2
Deaths
1
Hospitalizations
How Dangerous Is Muscular weakness From TECLISTAMAB-CQYV?
Of the 9 reports, 2 (22.2%) resulted in death, 1 (11.1%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which TECLISTAMAB-CQYV Alternatives Have Lower Muscular weakness Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL